Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups

Experimental and Molecular Pathology

Volumn 76, Issue 3, 2004, Pages 224-233

  Seidler, Heinrich B K ^a   Utsuyama, Masanori ^a   Nagaoka, Sakae ^b   Takemura, Tamiko ^b   Kitagawa, Masanobu ^a   Hirokawa, Katsuiku ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Aging; Beta catenin; c Myc; Cancer behavior; Colorectal cancer; Wnt signaling

Indexed keywords

BETA CATENIN; MYC PROTEIN; WNT PROTEIN;

ADULT; AGE; AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; COLORECTAL CANCER; CORRELATION ANALYSIS; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; BETA CATENIN; CELL NUCLEUS; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 2342560611     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2003.12.004     Document Type: Article

References (42)

1. Amati B., Alevizopoulos K., Vlach J. Myc and the cell cycle. Front. Biosci. 3:1998;D250-D268
2. Arai T., Takubo K., Sawabe M., Esaki Y. Pathologic characteristics of colorectal cancer in the elderly, a retrospective study of 947 surgical cases. J. Clin. Gastroenterol. 31:2000;67-72
3. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642
4. Borre A., Cultraro C.M., Segal S. c-Myc inactivation by mutant max alters growth and morphology of NCI-H-630 colon cancer cells. J. Cell. Physiol. 169:1996;200-208
5. Brabletz T., Jung A., Reu S., Porzner M., Hlubek F., Kunz-Schughart L.A., Knuechel R., Kirchner T. Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. U. S. A. 98:2001;10356-10361
6. Brabletz T., Jung A., Kirchner T. Beta-catenin and the morphogenesis of colorectal cancer. Virchows Arch. 441:2002;1-11
7. Cheah P.Y., Choo P.H., Yao J., Eu K.W., Seow-Choen F. A survival-stratification model of human colorectal carcinomas with beta-catenin and p27kip1. Cancer. 95:2002;2479-2486
8. Colorectal Cancer Colaborative Group (CCCG) Surgery for colorectal cancer in elderly patients, a systematic review. Lancet. 356:2000;968-974
9. Conacci-Sorrell M., Zhurinsky J., Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest. 109:2002;987-991
10. DePinho R.A. The age of cancer. Nature. 408:2000;248-254
11. El-Bahrawy M.A., Poulsom R., Jeffery R., Talbot I., Alison M.R. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum. Pathol. 32:2001;1216-1224
12. Fodde R., Smits R., Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev., Cancer. 1:2001;55-67
13. Gerdes J., Lemke H., Baisch H., Wacker H.H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1984;1710-1715
14. Green D.W., Roh H., Pippin J.A., Drebin J.A. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. J. Surg. Res. 101:2001;16-20
15. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512
16. Hoffman B., Liebermann D.A. The proto-oncogene c-myc and apoptosis. Oncogene. 17:1998;3351-3357
17. Hugh T.J., Dillon S.A., Taylor B.A., Pignatelli M., Poston G.J., Kinsella A.R. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br. J. Cancer. 80:1999;1046-1051
18. Jass J.R., Young J., Leggett B.A. Evolution of colorectal cancer, change of pace and change of direction. J. Gastroenterol. Hepatol. 17:2002;17-26
19. Jessup J.M., McGinnis L.S., Steele G.D. Jr., Menck H.R., Winchester D.P. The national cancer data base. Report on colon cancer. Cancer. 78:1996;918-926
20. Kakisako K., Miyahara M., Uchino S., Adachi Y., Kitano S. Prognostic significance of c-myc mRNA expression assessed by semi-quantitative RT-PCR in patients with colorectal cancer. Oncol. Rep. 5:1998;441-445
21. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170
22. Kitaeva M.N., Grogan L., Williams J.P., Dimond E., Nakahara K., Hausner P., DeNobile J.W., Soballe P.W., Kirsch I.R. Mutations in beta-catenin are uncommon in colorectal cancer occurring in occasional replication error-positive tumors. Cancer Res. 57:1997;4478-4481
23. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 275:1997;1784-1787
24. Liang J.T., Huang K.C., Cheng A.L., Jeng Y.M., Wu M.S., Wang S.M. Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br. J. Surg. 90:2003;205-214
25. Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., Aoki T., Miki Y., Mori T., Nakamura Y. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1:1992;229-233
26. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1997;1787-1790
27. Munemitsu S., Albert I., Souza B., Rubinfeld B., Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3046-3050
28. Nagaoka S., Shiraishi J., Utsuyama M., Seki S., Takemura T., Kitagawa M., Sawabe M., Takubo K., Hirokawa K. Poor prognosis of colorectal cancer in patients over 80 years old is associated with down-regulation of tumor suppressor genes. J. Clin. Gastroenterol. 37:2003;48-54
29. Nakamura K.D., Turturro A., Hart R.W. Elevated c-myc expression in progeria fibroblasts. Biochem. Biophys. Res. Commun. 155:1988;996-1000
30. Parramore J.B., Wei J.P., Yeh K.A. Colorectal cancer in patients under forty, presentation and outcome. Am. Surg. 64:1998;563-567
31. Polakis P. The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9:1999;15-21
32. Powell S.M., Zilz N., Beazer-Barclay Y., Bryan T.M., Hamilton S.R., Thibodeau S.N., Vogelstein B., Kinzler K.W. APC mutations occur early during colorectal tumorigenesis. Nature. 359:1992;235-237
33. Roh H., Green D.W., Boswell C.B., Pippin J.A., Drebin J.A. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res. 61:2001;6563-6568
34. Saito T., Oda Y., Kawaguchi K., Tanaka K., Matsuda S., Tamiya S., Iwamoto Y., Tsuneyoshi M. Possible association between higher beta-catenin mRNA expression and mutated beta-catenin in sporadic desmoid tumors, real-time semiquantitative assay by TaqMan polymerase chain reaction. Lab. Invest. 82:2002;97-103
35. Sato K., Miyahara M., Saito T., Kobayashi M. c-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur. J. Cancer. 30:1994;1113-1117
36. Sikora K., Chan S., Evan G., Gabra H., Markham N., Stewart J., Watson J. c-myc oncogene expression in colorectal cancer. Cancer. 59:1987;1289-1295
37. Smith D.R., Myint T., Goh H.S. Over-expression of the c-myc proto-oncogene in colorectal carcinoma. Br. J. Cancer. 68:1993;407-413
38. Tanaka K., Nagaoka S., Takemura T., Arai T., Sawabe M., Takubo K., Sugihara K., Kitagawa M., Hirokawa K. Incidence of apoptosis increases with age in colorectal cancer. Exp. Gerontol. 37:2002;1469-1479
39. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:2002;241-250
40. Waldron R.P., Donovan I.A., Drumm J., Mottram S.N., Tedman S. Emergency presentation and mortality from colorectal cancer in the elderly. Br. J. Surg. 73:1986;214-216
41. Yancik R., Ries L.A. Cancer in older persons. Magnitude of the problem - How do we apply what we know? Cancer. 74:1994;1995-2003
42. Yang J.L., Ow K.T., Russell P.J., Ham J.M., Crowe P.J. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors. Ann. Surg. Oncol. 3:1996;574-579